106 views, By Medical Infralytix Pvt Ltd Moderna claimed promising findings from a small-sample study of their experimental customized cancer vaccine and Merck's Keytruda to treat patients with head and neck cancer.
|
205 views, By Yieldrive AG Zug, Switzerland: Moore Hong Kong, an international accounting and advisory firm, and Yieldrive AG, the Swiss fintech company, are joining forces in Asia to provide companies and financial institutions with AI-driven ESG data
|
429 views, By Medical Infralytix Pvt Ltd Moderna (MRNA) shares rose on Wednesday after the firm said that its experimental flu shot beat widely used vaccinations from Sanofi and GSK.
|
356 views, By Medical Infralytix Pvt Ltd Madrigal Pharmaceuticals (MDGL) said Wednesday that it expects to get FDA clearance for its nonalcoholic steatohepatitis medication in March, sending the company's shares skyrocketing.
|
294 views, By Medical Infralytix Pvt Ltd After Eli Lilly (LLY) decided to buy the biopharma company for $2.4 billion, shares of DICE Therapeutics (DICE) rocketed and reached an all-time high on Tuesday morning.
|
219 views, By Medical Infralytix Pvt Ltd Investors gambled on Novavax Inc. (NVAX) as a coronavirus vaccine winner in the early days of the pandemic. In just one year, the stock increased by a mind-boggling 2,700%.
|
176 views, By Medical Infralytix Pvt Ltd Novavax Inc. (NVAX) shares have lost more than 68% of their value this year. The heyday of NVAX as a high-flying pandemic stock looks to be over
|
344 views, By Medical Infralytix Pvt Ltd Novavax Inc. (NVAX) rocketed higher on Tuesday, despite the market's overall poor performance. At roughly 12:35 p.m., the stock was up 5.8% from the previous day's closing. With an increase of roughly 1.9% to $56.55 at the close.
|
329 views, By Medical Infralytix Pvt Ltd The bad news is that NVAX isn't outperforming the market today. The biotech company's stock has dropped 56% this year, while the S&P 500 has dropped roughly 6%. NVAX's stock has risen more than 3,400% in the last two years.
|
332 views, By Medical Infralytix Pvt Ltd On February 7th, ZBH announced that its Board of Directors has declared a pro rata dividend of 80.3% of ZimVie Inc.'s outstanding common shares to Zimmer Biomet stockholders of record on February 15, 2022.
|
323 views, By Medical Infralytix Pvt Ltd ABBV, a pharmaceutical business, had its stock tumble 10.5%. The 52-week low for the stock is $105.56 and the 52-week high is $175.91.
|